Functional Properties of Neuronal Nicotinic Receptors
Project Number2R01NS017574-21A1
Contact PI/Project LeaderCHIAPPINELLI, VINCENT A
Awardee OrganizationGEORGE WASHINGTON UNIVERSITY
Description
Abstract Text
DESCRIPTION (provided by applicant): Nicotinic acetylcholine receptors (nAChRs) are located in many brain regions and are known to participate in critical tasks including learning, memory, and vision. Activation of nAChRs by exogenous application of acetylcholine (ACh) or nicotine produces diverse functional responses. Presynaptic nAChRs mediate enhanced release of several neurotransmitters. Activation of postsynaptic nAChRs produces excitatory responses that can be sufficient to elicit action potentials in neurons. Although these findings are critically important, relatively little is known concerning the functional effects of endogenously released acetylcholine and the cholinergic modulation of physiologically important pathways in the visual system and basal ganglia. The major goal of this proposal is to enhance our understanding of the overall impact of nicotinic receptor activation by endogenous ACh on synaptic transmission at defined sites within brain slices. Key features of our approach include the use of well-characterized model systems (ventral lateral geniculate and lateral spiriform nucleus) with robust presynaptic and postsynaptic nicotinic responses, and our ability to examine the physiological significance of nicotinic modulation resulting from the electrically stimulated release of endogenous ACh. Localization of nAChR subtypes within the circuitry of these brain regions will allow us to construct a model for their roles in the processing of incoming information and the output of projection neurons. Functional studies will be done using whole cell patch-clamp electrophysiological recordings of single neuron activity in brain slices. The impact of cholinergic transmission at both nicotinic and muscarinic receptors will be evaluated in relationship to glutamatergic and GABAergic transmission. We will examine both short term and long term effects of activation of nicotinic receptors, and study developmental regulation of cholinergic modulation.
Cigarette smoking causes over 400,000 premature deaths per year in the USA. Nicotine is the addictive principle in tobacco, and acts at central nAChRs to create dependence. Nicotinic receptors also mediate enhanced cognition and visual attention, and are reduced in number in several neurodegenerative diseases. They are present at high densities in the visual system and basal ganglia, but their functional roles in these systems are poorly understood. This project will expand our knowledge of the roles of these receptors.
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
043990498
UEI
ECR5E2LU5BL6
Project Start Date
01-July-1981
Project End Date
30-November-2010
Budget Start Date
22-January-2007
Budget End Date
30-November-2007
Project Funding Information for 2007
Total Funding
$334,688
Direct Costs
$218,750
Indirect Costs
$115,938
Year
Funding IC
FY Total Cost by IC
2007
National Institute of Neurological Disorders and Stroke
$334,688
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2R01NS017574-21A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01NS017574-21A1
Patents
No Patents information available for 2R01NS017574-21A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01NS017574-21A1
Clinical Studies
No Clinical Studies information available for 2R01NS017574-21A1
News and More
Related News Releases
No news release information available for 2R01NS017574-21A1
History
No Historical information available for 2R01NS017574-21A1
Similar Projects
No Similar Projects information available for 2R01NS017574-21A1